Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metabolic Syndrome

Recruiting now

Conditions studied: Metabolic Syndrome

In brief

This retrospective cohort study evaluates the association between H. pylori persistence and insulin resistance severity (HOMA-IR) in 100 patients with metabolic syndrome at Novosibirsk's Center for New Medical Technologies (CNMT). Patients are divided into infected (n=50) and non-infected (n=50) groups, assessing metabolic parameters, gastro panel, and CRP. Primary endpoint: HOMA-IR differences; secondary: correlations with gastric inflammation and metabolic markers.

Key facts

Study ID

NCT07501858

Run by

Center of New Medical Technologies

People needed

100

Starts

2026-04-01

Expected to finish

2028-07-01

Last updated by the study team

2026-03-30

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Verified MS per NCEP-ATP III criteria.
• Ability to undergo all procedures (fasting blood draw, breath test, stool antigen, endoscopy/biopsy, anthropometry).

You may not qualify if…

• Current metabolic-influencing therapy.
• Acute/chronic infection or autoimmune flare.
• Interventional study participation in last 3 months.
• Planned surgery/long hospitalization.
• Active malignancies.
• Severe liver/kidney failure.
• Pregnancy/lactation.
• Gastric resection or upper GI reconstruction.
• Type 1 diabetes.

Where it is running

• Center of New Medical Technologies — Novosibirsk, Novosibirsk Oblast, Russia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.